Estimation of the censoring distribution in clinical trials
Clinical studies with time to event endpoints typically report the median follow-up (i.e., censoring) time for the subjects in the trial, alongside the median time to event. The reason for this is to provide information about the opportunity for subjects in the study to experience the event of inter...
Main Authors: | Shu Jiang, David Swanson, Rebecca A. Betensky |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865421001423 |
Similar Items
-
survivalBIV : Estimation of the Bivariate Distribution Function for Sequentially Ordered Events Under Univariate Censoring
by: Ana Moreira, et al.
Published: (2012-01-01) -
Analysis of antibody response to measles vaccine with censored data
by: Ali Reza Hatami, et al.
Published: (2010-01-01) -
Bayesian survival analysis for early detection of treatment effects in phase 3 clinical trials
by: Lucie Biard, et al.
Published: (2021-03-01) -
Application of the estimand framework for an emulated trial using reference based multiple imputation to investigate informative censoring
by: A. Atkinson, et al.
Published: (2024-10-01) -
Censored Quantile Regression Redux
by: Roger Koenker
Published: (2008-05-01)